JP2020524524A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020524524A5 JP2020524524A5 JP2020516379A JP2020516379A JP2020524524A5 JP 2020524524 A5 JP2020524524 A5 JP 2020524524A5 JP 2020516379 A JP2020516379 A JP 2020516379A JP 2020516379 A JP2020516379 A JP 2020516379A JP 2020524524 A5 JP2020524524 A5 JP 2020524524A5
- Authority
- JP
- Japan
- Prior art keywords
- cflar
- hla
- expression level
- melanoma
- normalized
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762511058P | 2017-05-25 | 2017-05-25 | |
| US62/511,058 | 2017-05-25 | ||
| PCT/US2018/033658 WO2018217627A1 (en) | 2017-05-25 | 2018-05-21 | Methods for melanoma detection |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020524524A JP2020524524A (ja) | 2020-08-20 |
| JP2020524524A5 true JP2020524524A5 (cg-RX-API-DMAC7.html) | 2021-07-26 |
| JP7227964B2 JP7227964B2 (ja) | 2023-02-22 |
Family
ID=62620988
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020516379A Active JP7227964B2 (ja) | 2017-05-25 | 2018-05-21 | 黒色腫の検出方法 |
Country Status (13)
| Country | Link |
|---|---|
| US (3) | US20180340934A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3631017B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7227964B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR102763004B1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN111315897B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2018273844B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112019024481A2 (cg-RX-API-DMAC7.html) |
| DK (1) | DK3631017T3 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2920288T3 (cg-RX-API-DMAC7.html) |
| IL (1) | IL270787B2 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2019014026A (cg-RX-API-DMAC7.html) |
| PL (1) | PL3631017T3 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2018217627A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2019014026A (es) | 2017-05-25 | 2020-08-03 | Liquid Biopsy Res Llc | Metodos para la deteccion de melanoma. |
| EP4041886A1 (en) | 2019-10-10 | 2022-08-17 | Liquid Biopsy Research LLC | Compositions, methods and kits for biological sample and rna stabilization |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2006203830A1 (en) * | 2005-01-07 | 2006-07-13 | The Johins Hopkins University | Biomarkers for melanoma |
| WO2008031041A2 (en) * | 2006-09-07 | 2008-03-13 | H. Lee Moffitt Cancer Center And Research Institute, Inc. | Melanoma gene signature |
| NZ576428A (en) * | 2006-11-03 | 2012-04-27 | Baylor Res Inst | Diagnosis of metastatic melanoma and monitoring indicators of immunosuppression through blood leukocyte microarray analysis |
| EP2092075A2 (en) | 2006-11-06 | 2009-08-26 | Source Precision Medicine, Inc. | Gene expression profiling for identification, monitoring and treatment of melanoma |
| US20110070582A1 (en) | 2008-11-03 | 2011-03-24 | Source Precision Medicine, Inc. d/b/d Source MDX | Gene Expression Profiling for Predicting the Response to Immunotherapy and/or the Survivability of Melanoma Subjects |
| CN102667484A (zh) * | 2009-10-13 | 2012-09-12 | 约翰·霍普金斯大学 | 识别黑素瘤肿瘤细胞的生物标记 |
| WO2012031008A2 (en) | 2010-08-31 | 2012-03-08 | The General Hospital Corporation | Cancer-related biological materials in microvesicles |
| WO2014008270A1 (en) * | 2012-07-03 | 2014-01-09 | Ratiopharm Gmbh | Solid state form of vemurafenib choline salt |
| US10407730B2 (en) * | 2014-09-15 | 2019-09-10 | Clifton Life Sciences LLC | Compositions, methods and kits for diagnosis of a gastroenteropancreatic neuroendocrine neoplasm |
| MX2019014026A (es) | 2017-05-25 | 2020-08-03 | Liquid Biopsy Res Llc | Metodos para la deteccion de melanoma. |
-
2018
- 2018-05-21 MX MX2019014026A patent/MX2019014026A/es unknown
- 2018-05-21 PL PL18731615.3T patent/PL3631017T3/pl unknown
- 2018-05-21 ES ES18731615T patent/ES2920288T3/es active Active
- 2018-05-21 DK DK18731615.3T patent/DK3631017T3/da active
- 2018-05-21 KR KR1020197038285A patent/KR102763004B1/ko active Active
- 2018-05-21 US US15/984,935 patent/US20180340934A1/en not_active Abandoned
- 2018-05-21 JP JP2020516379A patent/JP7227964B2/ja active Active
- 2018-05-21 WO PCT/US2018/033658 patent/WO2018217627A1/en not_active Ceased
- 2018-05-21 EP EP18731615.3A patent/EP3631017B1/en active Active
- 2018-05-21 BR BR112019024481-6A patent/BR112019024481A2/pt active Search and Examination
- 2018-05-21 AU AU2018273844A patent/AU2018273844B2/en active Active
- 2018-05-21 CN CN201880049298.1A patent/CN111315897B/zh active Active
-
2019
- 2019-11-20 IL IL270787A patent/IL270787B2/en unknown
-
2021
- 2021-09-30 US US17/490,433 patent/US12399179B2/en active Active
-
2025
- 2025-08-04 US US19/290,017 patent/US20260202409A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20220396842A1 (en) | Method for using gene expression to determine prognosis of prostate cancer | |
| EP3189156B1 (en) | Thyroid cancer diagnosis by dna methylation analysis | |
| JP5415963B2 (ja) | 新しい癌マーカー | |
| JP7111630B2 (ja) | 炎症性腸疾患用のバイオマーカー | |
| JP2017528164A5 (cg-RX-API-DMAC7.html) | ||
| JP2018524972A (ja) | 肺癌の診断または検出のための方法及び組成物 | |
| JP2021514624A5 (cg-RX-API-DMAC7.html) | ||
| JP2017060515A (ja) | 遺伝子の発現を分析することによって患者における癌の転帰を予測するための方法 | |
| JP2024523848A (ja) | 癌検出方法、キットおよびシステム | |
| US20210277479A1 (en) | Risk scores based on human phosphodiesterase 4 d variant 7 expression | |
| JP2021511057A5 (cg-RX-API-DMAC7.html) | ||
| CA2989480C (en) | Kit and method for the diagnosis/prognosis of idiopathic scoliosis | |
| CN107858434B (zh) | lncRNA在肝癌诊断以及预后预测中的应用 | |
| HK1253908A1 (en) | Method for the diagnosis/prognosis of adolescent idiopathic scoliosis | |
| JP2020528274A5 (cg-RX-API-DMAC7.html) | ||
| JP7084034B2 (ja) | 神経芽腫の微小残存病変を評価するために用いられる試薬、およびそれを用いた生体試料の分析方法 | |
| CN104498495A (zh) | 前列腺癌标志物lncRNA MALAT-1及其应用 | |
| JP2019512212A (ja) | 活動性結核を検出するための方法 | |
| JP2017529094A5 (cg-RX-API-DMAC7.html) | ||
| WO2017102902A1 (en) | Micrornas as predictive biomarkers of type 1 diabetes | |
| IL317236A (en) | Predicting peptide receptor radiotherapy using gene expression testing | |
| CN111315897B (zh) | 用于黑素瘤检测的方法 | |
| JP2024170603A (ja) | 免疫チェックポイント阻害療法からの利益を予測する方法 | |
| JP2026510430A (ja) | がん診断モデルを開発する方法及びがん検出方法の開発におけるその使用 | |
| US20170130277A1 (en) | Biomarker for colorectal cancer |